CFR PHARMACEUTICALS

CFR Pharmaceuticals is a leading multinational pharmaceutical company with operations in 15 countries in Latin America (mainly Chile, Peru, Argentina and Colombia), and other emerging markets. Its business model is focused on the development, manufacture and commercialization of branded generics specialty products. The company manages its operations along several business segments including: Drugtech (neurology, psychiatry and cardiology), Gynopharm (women's health), Recalcine (acute therapeutic areas), Biomedical Sciences (monoclonal antibodies and treatments related to transplants, dialysis, oncology and rheumatology), Complex Injectables (sterile injectable products and lyophilized forms, for anesthesia, infectious diseases, cardiology and critical care); among others.